StockDocs
Project by Matthew Castle Please send feedback to matthewgcastle@gmail.com
MEDP

Medpace Holdings, Inc.

MEDP Nasdaq Services-Commercial Physical & Biological Research EDGAR ↗
$573.29
-5.01 -0.87%

Key statistics

from XBRL data in SEC filings
Market cap
$16.0B
Revenue (TTM)
$2.78B
Net income (TTM)
$492M
EPS (TTM)
$17.04
P/E ratio
33.6
Dividend yield
Free cash flow
$682M
Cash
$503M
Total assets
$2.06B
Gross margin
52-week range
$373.00 – $677.90

Recent SEC filings

40 most recent
Annual, quarterly & current reports
10-Q Quarter ended 2026-06-30 Jul 23, 2026 8-K Results of operations (earnings release) Jul 22, 2026 8-K Director or officer change Jun 4, 2026 8-K Amended charter or bylaws; Shareholder vote results May 19, 2026 10-Q Quarter ended 2026-03-31 Apr 23, 2026 8-K Results of operations (earnings release); Director or officer change Apr 22, 2026 10-K Fiscal year ended 2025-12-31 Feb 10, 2026 8-K Results of operations (earnings release) Feb 9, 2026 10-Q Quarter ended 2025-09-30 Oct 23, 2025 8-K Results of operations (earnings release) Oct 22, 2025 10-Q Quarter ended 2025-06-30 Jul 22, 2025 8-K Entered a material agreement; Results of operations (earnings release) Jul 21, 2025 8-K Director or officer change; Shareholder vote results May 16, 2025 10-Q Quarter ended 2025-03-31 Apr 22, 2025 8-K Entered a material agreement; Results of operations (earnings release); Other events Apr 21, 2025 8-K Entered a material agreement Mar 31, 2025 10-K Fiscal year ended 2024-12-31 Feb 11, 2025 8-K Results of operations (earnings release); Other events Feb 10, 2025 10-Q Quarter ended 2024-09-30 Oct 22, 2024 8-K Results of operations (earnings release) Oct 21, 2024 10-Q Quarter ended 2024-06-30 Jul 23, 2024 8-K Results of operations (earnings release) Jul 22, 2024 8-K Director or officer change Jul 3, 2024 8-K Amended charter or bylaws; Shareholder vote results May 21, 2024 10-Q Quarter ended 2024-03-31 Apr 23, 2024 8-K Results of operations (earnings release) Apr 22, 2024 8-K Entered a material agreement Mar 29, 2024 10-K Fiscal year ended 2023-12-31 Feb 13, 2024 8-K Results of operations (earnings release) Feb 12, 2024 10-Q Quarter ended 2023-09-30 Oct 24, 2023 8-K Results of operations (earnings release) Oct 23, 2023 10-Q Quarter ended 2023-06-30 Jul 25, 2023 8-K Results of operations (earnings release) Jul 24, 2023 8-K Shareholder vote results May 19, 2023 10-Q Quarter ended 2023-03-31 Apr 25, 2023 8-K Results of operations (earnings release) Apr 24, 2023 8-K Entered a material agreement Mar 31, 2023 10-K Fiscal year ended 2022-12-31 Feb 14, 2023 8-K Results of operations (earnings release) Feb 13, 2023 8-K Director or officer change Jan 18, 2023